학술논문
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Document Type
Article
Author
Source
In The Lancet 29 October-4 November 2016 388(10056):2115-2127
Subject
Language
ISSN
0140-6736